On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review

Neuroscience and Biobehavioral Reviews

Volumn 83, Issue , 2017, Pages 97-108

  Pinto, Jairo Vinícius ^a   Moulin, Thiago C ^b   Amaral, Olavo B ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Biomarkers; Bipolar disorder; Major depressive disorder; Molecular; Peripheral; Schizophrenia; Transdiagnostic

Indexed keywords

4 AMINOBUTYRIC ACID; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CORTICOTROPIN; DOPAMINE; FIBRINOGEN; GAMMA INTERFERON; GLUCOSE; GLUTAMIC ACID; GLUTATHIONE; HOMOCYSTEINE; HYDROCORTISONE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; KYNURENINE; LEPTIN; MOLECULAR MARKER; NEUROTROPHIN 3; NITRIC OXIDE; PROLACTIN; PROTEIN S100B; SEROTONIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ATTENTION DEFICIT DISORDER; AUTISM; BIPOLAR DISORDER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; MOLECULAR DIAGNOSIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; BLOOD;

BIOMARKERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS; MENTAL DISORDERS; SCHIZOPHRENIA;

EID: 85031004548     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2017.10.001     Document Type: Review

References (86)

1. Arana, G.W., The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch. Gen. Psychiatry, 42, 1985, 1193, 10.1001/archpsyc.1985.01790350067012.
2. Belvederi Murri, M., Prestia, D., Mondelli, V., Pariante, C., Patti, S., Olivieri, B., Arzani, C., Masotti, M., Respino, M., Antonioli, M., Vassallo, L., Serafini, G., Perna, G., Pompili, M., Amore, M., The HPA axis in bipolar disorder: systematic review and meta-analysis. Psychoneuroendocrinology 63 (2016), 327–342, 10.1016/j.psyneuen.2015.10.014.
3. Bilello, J.A., Thurmond, L.M., Smith, K.M., Pi, B., Rubin, R., Wright, S.M., Taub, F., Henry, M.E., Shelton, R.C., Papakostas, G.I., MDDScore: confirmation of a blood test to aid in the diagnosis of major depressive disorder. J. Clin. Psychiatry 76 (2015), e199–206, 10.4088/JCP.14m09029.
4. Bosker, F.J., Hartman, C.A., Nolte, I.M., Prins, B.P., Terpstra, P., Posthuma, D., van Veen, T., Willemsen, G., DeRijk, R.H., de Geus, E.J., Hoogendijk, W.J., Sullivan, P.F., Penninx, B.W., Boomsma, D.I., Snieder, H., Nolen, W.A., Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol. Psychiatry 16 (2011), 516–532, 10.1038/mp.2010.38.
5. Carvalho, A.F., Köhler, C.A., Fernandes, B.S., Quevedo, J., Miskowiak, K.W., Brunoni, A.R., Machado-Vieira, R., Maes, M., Vieta, E., Berk, M., Bias in emerging biomarkers for bipolar disorder. Psychol. Med. 46 (2016), 1–11, 10.1017/S0033291716000957.
6. Caspi, A., Houts, R.M., Belsky, D.W., Goldman-Mellor, S.J., Harrington, H., Israel, S., Meier, M.H., Ramrakha, S., Shalev, I., Poulton, R., Moffitt, T.E., The p factor: one general psychopathology factor in the structure of psychiatric disorders? Clin. Psychol. Sci. 2 (2014), 119–137, 10.1177/2167702613497473.
7. Chouinard, G., The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. J. Psychiatry Neurosci. 31 (2006), 168–176.
8. Collins, A.L., Sullivan, P.F., Corvin, A., Craddock, N., Sullivan, P., Sullivan, P., de Geus, E., Willemsen, G., James, M., Smit, J., Zandbelt, T., Sullivan, P., Daly, M., O'Donovan, M., Collins, A., Kim, Y., Sklar, P., O'Donovan, M., Sullivan, P., Visscher, P., Brown, M., McCarthy, M., Yang, J., Sullivan, P., Genome-wide association studies in psychiatry: what have we learned?. Br. J. Psychiatry 202 (2013), 1–4, 10.1192/bjp.bp.112.117002.
9. Cordero, O.J., De Chiara, L., Lemos-González, Y., Páez de lad Cadena, M., Rodríguez-Berrocal, F.J., How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer. Anticancer Res. 28 (2008), 2333–2341.
10. Cuthbert, B.N., Insel, T.R., Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med., 11, 2013, 126, 10.1186/1741-7015-11-126.
11. Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G.D.O., Pepys, M.B., Gudnason, V., C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350 (2004), 1387–1397, 10.1056/NEJMoa032804.
12. Dargel, A.A., Godin, O., Kapczinski, F., Kupfer, D.J., Leboyer, M., C-reactive protein alterations in bipolar disorder: a meta-analysis. J. Clin. Psychiatry 76 (2015), 142–150, 10.4088/JCP.14r09007.
13. Davis, J., Maes, M., Andreazza, a, McGrath, J.J., Tye, S.J., Berk, M., Towards a classification of biomarkers of neuropsychiatric disease: from encompass to compass. Mol. Psychiatry 20 (2014), 152–153, 10.1038/mp.2014.139.
14. del Campo, M., Jongbloed, W., Twaalfhoven, H.A.M., Veerhuis, R., Blankenstein, M.A., Teunisse, C.E., Facilitating the validation of novel protein biomarker for dementia: an optimal workflow for the development of sandwich immunoassays. Front. Neurol., 6, 2015, 202, 10.3389/fneur.2015.00202.
15. Dickerson, S.S., Kemeny, M.E., Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 130 (2004), 355–391, 10.1037/0033-2909.130.3.355.
16. Domenici, E., Willé, D.R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C.W., Holsboer, F., Bullmore, E.T., Middleton, L., Merlo-Pich, E., Alexander, R.C., Muglia, P., Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One, 5, 2010, e9166, 10.1371/journal.pone.0009166.
17. Duman, R.S., Monteggia, L.M., A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006), 1116–1127, 10.1016/j.biopsych.2006.02.013.
18. Dwan, K., Altman, D.G., Arnaiz, J.A., Bloom, J., Chan, A.-W., Cronin, E., Decullier, E., Easterbrook, P.J., Von Elm, E., Gamble, C., Ghersi, D., Ioannidis, J.P.A., Simes, J., Williamson, P.R., Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One, 3, 2008, e3081, 10.1371/journal.pone.0003081.
19. Ellenbogen, M.A., Hodgins, S., Linnen, A.-M., Ostiguy, C.S., Elevated daytime cortisol levels: a biomarker of subsequent major affective disorder?. J. Affect. Disord. 132 (2011), 265–269, 10.1016/j.jad.2011.01.007.
20. Fernandes, B.S., Gama, C.S., Kauer-Sant'Anna, M., Lobato, M.I., Belmonte-de-Abreu, P., Kapczinski, F., Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J. Psychiatr. Res., 43, 2009, 10.1016/j.jpsychires.2009.04.010.
21. Fernandes, B.S., Berk, M., Turck, C.W., Steiner, J., Gonçalves, C., Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol. Psychiatry, 749–751, 2013, 10.1038/mp.2013.172.
22. Fernandes, B.S., Molendijk, M.L., Köhler, C.A., Soares, J.C., Leite, C.M.G.S., Machado-Vieira, R., Ribeiro, T.L., Silva, J.C., Sales, P.M.G., Quevedo, J., Oertel-Knöchel, V., Vieta, E., González-Pinto, A., Berk, M., Carvalho, A.F., Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med., 13, 2015, 289, 10.1186/s12916-015-0529-7.
23. Fernandes, B.S., Steiner, J., Berk, M., Molendijk, M.L., Turck, C.W., Nardin, P., Gonçalves, C., Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications. Mol. Psychiatry 20 (2015), 1108–1119, 10.1038/mp.2014.117.
24. Fernandes, B.S., Steiner, J., Bernstein, H.-G., Dodd, S., Pasco, J.A., Dean, O.M., Nardin, P., Goncalves, C.-A., Berk, M., C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol. Psychiatry 21 (2016), 554–564, 10.1038/mp.2015.87.
25. Fernandes, B.S., Steiner, J., Molendijk, M.L., Dodd, S., Nardin, P., Goncalves, C.-A., Jacka, F., Kohler, C.A., Karmakar, C., Carvalho, A.F., Berk, M., C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry 3 (2016), 1147–1156, 10.1016/S2215-0366(16)30370-4.
26. Frye, M.A., Nassan, M., Jenkins, G.D., Kung, S., Veldic, M., Palmer, B.A., Feeder, S.E., Tye, S.J., Choi, D.S., Biernacka, J.M., Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders Transl. Psychiatry, 5, 2015, e689, 10.1038/tp.2015.185.
27. Girshkin, L., Matheson, S.L., Shepherd, A.M., Green, M.J., Morning cortisol levels in schizophrenia and bipolar disorder: a meta-analysis. Psychoneuroendocrinology 49 (2014), 187–206, 10.1016/j.psyneuen.2014.07.013.
28. Gnanapavan, S., Hegen, H., Khalil, M., Hemmer, B., Franciotta, D., Hughes, S., Hintzen, R., Jeromin, A., Havrdova, E., Tumani, H., Bertolotto, A., Comabella, M., Frederiksen, J., Álvarez-Cermeño, J.C., Villar, L., Galimberti, D., Myhr, K.-M., Dujmovic, I., Fazekas, F., Ionete, C., Menge, T., Kuhle, J., Keir, G., Deisenhammer, F., Teunissen, C., Giovannoni, G., Guidelines for uniform reporting of body fluid biomarker studies in neurologic disorders. Neurology 83 (2014), 1210–1216, 10.1212/WNL.0000000000000809.
29. Gold, P.W., The organization of the stress system and its dysregulation in depressive illness. Mol. Psychiatry 20 (2015), 32–47, 10.1038/mp.2014.163.
30. Goldsmith, D.R., Rapaport, M.H., Miller, B.J., A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol. Psychiatry 12 (2016), 1696–1709, 10.1038/mp.2016.3.
31. Goodkind, M., Eickhoff, S.B., Oathes, D.J., Jiang, Y., Chang, A., Jones-Hagata, L.B., Ortega, B.N., Zaiko, Y.V., Roach, E.L., Korgaonkar, M.S., Grieve, S.M., Galatzer-Levy, I., Fox, P.T., Etkin, A., Identification of a common neurobiological substrate for mental illness. JAMA Psychiatry 72 (2015), 305–315, 10.1001/jamapsychiatry.2014.2206.
32. Haag, A.L., Biomarkers trump behavior in mental illness diagnosis. Nat. Med., 13, 2007, 3, 10.1038/nm0107-3.
33. Haapakoski, R., Mathieu, J., Ebmeier, K.P., Alenius, H., Kivimaki, M., Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder. Brain. Behav. Immun. 49 (2015), 206–215, 10.1016/j.bbi.2015.06.001.
34. Heinrichs, R.W., Meta-analysis and the science of schizophrenia: variant evidence or evidence of variants? Neurosci. Biobehav. Rev. 28 (2004), 379–394, 10.1016/j.neubiorev.2004.06.003.
35. Higginson, A.D., Munafò, M.R., Current incentives for scientists lead to underpowered studies with erroneous conclusions. PLoS Biol., 14, 2016, e2000995, 10.1371/journal.pbio.2000995.
36. Hyman, S.E., The diagnosis of mental disorders: the problem of reification. Annu. Rev. Clin. Psychol. 6 (2010), 155–179, 10.1146/annurev.clinpsy.3.022806.091532.
37. Insel, T.R., Quirion, R., Psychiatry as a clinical neuroscience discipline. JAMA 294 (2005), 2221–2224, 10.1001/jama.294.17.2221.
38. Ioannidis, J.P.A., Why most published research findings are false. PLoS Med., 2005, 2, 10.1371/journal.pmed.0020124.
39. Joyner, M.J., Paneth, N., Ioannidis, J.P.A., What happens when underperforming big ideas in research become entrenched?. JAMA, 316, 2016, 1355, 10.1001/jama.2016.11076.
40. Kapczinski, F., Vieta, E., Andreazza, A.C., Frey, B.N., Gomes, F.A., Tramontina, J., Kauer-Sant'Anna, M., Grassi-Oliveira, R., Post, R.M., Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci. Biobehav. Rev. 32 (2008), 675–692, 10.1016/j.neubiorev.2007.10.005.
41. Kapczinski, F., Videira, V., Anna, M.K., Brietzke, E., Vázquez, G.H., Vieta, E., Berk, M., The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 33 (2009), 1366–1371, 10.1016/j.pnpbp.2009.07.027.
42. Kapczinski, F., Dal-Pizzol, F., Teixeira, A.L., Magalhaes, P.V.S., Kauer-Sant'Anna, M., Klamt, F., Pasquali, M., a, D.B., Quevedo, J., Gama, C.S., Post, R., A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol. Psychiatry 15 (2010), 784–786, 10.1038/mp.2009.112.
43. Kapur, S., Phillips, a G., Insel, T.R., Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol. Psychiatry 17 (2012), 1174–1179, 10.1038/mp.2012.105.
44. Kauer-Sant'Anna, M., Tramontina, J., Andreazza, A.C., Cereser, K., da Costa, S., Santin, A., Yatham, L.N., Kapczinski, F., Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathology. Bipolar Disord. Suppl. 9 (2007), 128–135, 10.1111/j.1399-5618.2007.00478. x.
45. Kendler, K.S., Reflections on the relationship between psychiatric genetics and psychiatric nosology. Am. J. Psychiatry 163 (2006), 1138–1146, 10.1176/appi.ajp.163.7.1138.
46. Kendler, K.S., What psychiatric genetics has taught us about the nature of psychiatric illness and what is left to learn. Mol. Psychiatry 18 (2013), 1058–1066, 10.1038/mp.2013.50.
47. Kennedy, S.H., Downar, J., Evans, K.R., Feilotter, H., Lam, R.W., MacQueen, G.M., Milev, R., Parikh, S.V., Rotzinger, S., Soares, C., The Canadian Biomarker Integration Network in Depression (CAN-BIND): advances in response prediction. Curr. Pharm. Des. 18 (2012), 5976–5989, 10.2174/138161212803523635.
48. Kessing, L.V., Munkholm, K., Faurholt-Jepsen, M., Miskowiak, K.W., Nielsen, L.B., Frikke-Schmidt, R., Ekstrøm, C., Winther, O., Pedersen, B.K., Poulsen, H.E., McIntyre, R.S., Kapczinsk, F., Gattaz, W.F., Bardram, J., Frost, M., Mayora, O., Knudsen, G.M., Phillips, M., Vinberg, M., The Bipolar Illness Onset study: research protocol for the BIO cohort study. BMJ Open., 7, 2017, e015462, 10.1136/bmjopen-2016-015462.
49. Kivimaki, M., Singh-Manoux, A., Ferrie, J.E., Batty, G.D., Post hoc decision-making in observational epidemiology-is there need for better research standards?. Int. J. Epidemiol. 42 (2013), 367–370, 10.1093/ije/dyt036.
50. Kupfer, D., First, M.B., Regier, D.A., A Research Agenda for DSM-V. American Psychiatric Association, 2002, 10.1176/appi.ps.54.6.916.
51. Lancet Psychiatry, Blood biomarkers in psychiatry. Lancet Psychiatry, 3, 2016, 693, 10.1016/S2215-0366(16)30176-6.
52. Lee, K.L., McNeer, J.F., Starmer, C.F., Harris, P.J., Rosati, R.A., Clinical judgment and statistics. Lessons froma simulated randomized trial in coronary artery disease. Circulation. 61 (1980), 508–515, 10.1161/01.CIR.61 3.508.
53. Li, Z., Zhang, C., Fan, J., Yuan, C., Huang, J., Chen, J., Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study. Br. J. Psychiatry 205 (2014), 29–35, 10.1192/bjp.bp.113.134064.
54. Martín, F., Santolaria, F., Batista, N., Milena, A., González-Reimers, E., Brito, M.J., Oramas, J., Cytokine levels (IL-6 and IFNγ), acute phase response and nutritional status as prognostic factors in lung cancer. Cytokine 11 (1999), 80–86, 10.1006/cyto.1998.0398.
55. McEwen, B.S., Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87 (2007), 873–904, 10.1152/physrev.00041.2006.
56. Mendall, M.A., Patel, P., Asante, M., Ballam, L., Morris, J., Strachan, D.P., Camm, A.J., Northfield, T.C., Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart 78 (1997), 273–277, 10.1136/hrt.78.3.273.
57. Modabbernia, A., Taslimi, S., Brietzke, E., Ashrafi, M., Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies. Biol. Psychiatry 74 (2013), 15–25, 10.1016/j.biopsych.2013.01.007.
58. Munkholm, K., Vinberg, M., Kessing, L.V., Cytokines in bipolar disorder: A systematic review and meta-analysis. J. Affect. Disord. 144 (2013), 16–27, 10.1016/j.jad.2012.06.010.
59. Munkholm, K., Vinberg, M., Kessing, L.V., Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol. Psychiatry 21 (2016), 216–228, 10.1038/mp.2015.54.
60. Nutt, A.E., Brain Hacking: The Mind's Biology. 2016, The Washington Post ( http://www.washingtonpost.com/sf/national/2016/02/19/brain-hacking-the-minds-biology). Accessed 21 February 2017.
61. Olfson, M., Gerhard, T., Huang, C., Crystal, S., Stroup, T.S., Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72 (2015), 1172–1181, 10.1001/jamapsychiatry.2015.1737.
62. Ösby, U., Westman, J., Hällgren, J., Gissler, M., Mortality trends in cardiovascular causes in schizophrenia, bipolar and unipolar mood disorder in Sweden 1987–2010. Eur. J. Public Health 26 (2016), 867–871, 10.1093/eurpub/ckv245.
63. Owens, M., Herbert, J., Jones, P.B., Sahakian, B.J., Wilkinson, P.O., Dunn, V.J., Croudace, T.J., Goodyer, I.M., Elevated morning cortisol is a stratified population-level biomarker for major depression in boys only with high depressive symptoms. Proc. Natl. Acad. Sci. USA. 111 (2014), 3638–3643, 10.1073/pnas.1318786111.
64. Papakostas, G.I., Shelton, R.C., Kinrys, G., Henry, M.E., Bakow, B.R., Lipkin, S.H., Pi, B., Thurmond, L., Bilello, J.A., Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study. Mol. Psychiatry 18 (2013), 332–339, 10.1038/mp.2011.166.
65. Pavão, R., Tort, A.B.L., Amaral, O.B., Multifactoriality in psychiatric disorders: a computational study of schizophrenia. Schizophr. Bull. 41 (2015), 980–988, 10.1093/schbul/sbu146.
66. Perlis, R.H., Translating biomarkers to clinical practice. Mol. Psychiatry 16 (2011), 1076–1087, 10.1038/mp.2011.63.
67. Polyakova, M., Stuke, K., Schuemberg, K., Mueller, K., Schoenknecht, P., Schroeter, M.L., BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis. J. Affect. Disord. 174 (2015), 432–440, 10.1016/j.jad.2014.11.044.
68. Rapaport, M.H., Nierenberg, A.A., Schettler, P.J., Kinkhead, B., Cardoos, A., Walker, R., Mischoulon, D., Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study. Mol. Psychiatry 21 (2016), 71–79, 10.1038/mp;2015.22.
69. Rich, T., Innominato, P.F., Boerner, J., Mormont, M.C., Iacobelli, S., Baron, B., Jasmin, C., Lévi, F., Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin. Cancer Res. 11 (2005), 1757–1764, 10.1158/1078-0432.ccr-04-2000.
70. Schwarz, E., Guest, P.C., Rahmoune, H., Martins-de-Souza, D., Niebuhr, D.W., Weber, N.S., Cowan, D.N., Yolken, R.H., Spain, M., Barnes, A., Bahn, S., Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation. World J. Biol. Psychiatry 13 (2012), 627–632, 10.3109/15622975.2011.599861.
71. Siontis, K.C.M., Patsopoulos, N.a, Ioannidis, J.P.a, Replication of past candidate loci for common diseases and phenotypes in 100 genome-wide association studies. Eur. J. Hum. Genet. 18 (2010), 832–837, 10.1038/ejhg.2010.26.
72. Slavich, G.M., Way, B.M., Eisenberger, N.I., Taylor, S.E., Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 14817–14822, 10.1073/pnas.1009164107.
73. Smaldino, P.E., McElreath, R., The natural selection of bad science. R. Soc. Open Sci., 3, 2016, 160384, 10.1098/rsos.160384.
74. Smith, G.D., Ben-Shlomo, Y., Beswick, A., Yarnell, J., Lightman, S., Elwood, P., Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study. Circulation 112 (2005), 332–340, 10.1161/CIRCULATIONAHA.104.489088.
75. Smoller, J.W., Identification of risk loci with shared effects on five major psychiatric disorders: A genome-wide analysis. Lancet 381 (2013), 1371–1379, 10.1016/S0140-6736(12)62129-1.
76. Sprooten, E., Rasgon, A., Goodman, M., Carlin, A., Leibu, E., Lee, W.H., Frangou, S., Addressing reverse inference in psychiatric neuroimaging: Meta-analyses of task-related brain activation in common mental disorders. Hum. Brain Mapp. 38 (2017), 1846–1864, 10.1002/hbm.23486.
77. Steptoe, A., Hamer, M., Chida, Y., The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain. Behav. Immun. 21 (2007), 901–912, 10.1016/j.bbi.2007.03.011.
78. Sterne, J., Davey Smith, G., Sifting the evidence-what's wrong with significance tests?. BMJ 322 (2001), 226–231, 10.1136/bmj.322.7280.226.
79. Stetler, C., Miller, G.E., Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom. Med. 73 (2011), 114–126, 10.1097/PSY.0b013e31820ad12b.
80. Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., Cleare, A.J., Inflammation and clinical response to treatment in depression: a meta-analysis. Eur. Neuropsychopharmacol. 25 (2015), 1532–1543, 10.1016/j.euroneuro.2015.06.007.
81. Sullivan, P.F., The Psychiatric GWAS Consortium: Big science comes to psychiatry. Neuron 21 (2010), 182–186, 10.1016/j.neuron.2010.10.003.
82. Uher, R., Tansey, K.E., De, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M.Z., Henigsber, N., Souey, D., Farmer, A., McGuffin, P., An inflammatory biomarker as a differenctial predictor of outcome of depression treatment with escitalopram and nortryptiline. Am. J. Psychiatry. 171 (2014), 1278–1286, 10.1176/appi.ajp.2014.14010094.
83. Valkanova, V., Ebmeier, K.P., Allan, C.L., CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 150 (2013), 7636–7644, 10.1016/j.jad.2013.06.004.
84. Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study. Schizophr. Bull. 40 (2014), 1117–1127, 10.1093/schbul/sbt120.
85. Wohleb, E.S., Franklin, T., Iwata, M., Duman, R.S., Integrating neuroimmune systems in the neurobiology of depression. Nat. Rev. Neurosci. 17 (2016), 497–511, 10.1038/nrn.2016.69.
86. Zachar, P., Kendler, K.S., The philosophy of nosology. Annu. Rev. Clin. Psychol. 13 (2017), 49–71, 10.1146/annurev-clinpsy-032816-045020.